WAKE FOREST SCHOOL OF MEDICINE, INSTITUTE FOR REGENERATIVE MEDICINE

Lobbying Spend

—

Filings

Firms Hired

Active Period

2008–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	4	1
2008	—	7	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
STAPLETON & ASSOCIATES, LLC	—	71

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	22
SENATE	22
Defense, Dept of (DOD)	6
Health & Human Services, Dept of (HHS)	5
Veterans Affairs, Dept of (VA)	5

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	12
Defense	Defense	11
Veterans	Veterans	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3326110th Congress

Early Treatment for HIV Act of 2007

2009 · fourth_quarter · Firm: STAPLETON & ASSOCIATES, LLC

Cited source text and reported amounts

Regenerative Medicine H.R. 3326, Department of Defense Appropriations Act, 2010. S. 1390, National Defense Authorization Act for Fiscal Year 2010.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 3326